These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 22592504

  • 1. St John's wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT.
    Sarris J, Fava M, Schweitzer I, Mischoulon D.
    Pharmacopsychiatry; 2012 Nov; 45(7):275-8. PubMed ID: 22592504
    [Abstract] [Full Text] [Related]

  • 2. Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial.
    Hypericum Depression Trial Study Group, Davidson JR, Gadde KM, Fairbank JA, Krishnan KRR, Califf RM, Binanay C, Parker CB, Pugh N, Hartwell TD, Vitiello B, Ritz L, Severe J, Cole JO, de Battista C, Doraiswamy PM, Feighner JP, Keck P, Kelsey J, Lin KM, Londborg PD, Nemeroff CB, Schatzberg AF, Sheehan DV, Srivastava RK, Taylor L, Trivedi MH, Weisler RH.
    JAMA; 2002 Apr 10; 287(14):1807-14. PubMed ID: 11939866
    [Abstract] [Full Text] [Related]

  • 3. St John's wort or sertraline? Randomized controlled trial in primary care.
    van Gurp G, Meterissian GB, Haiek LN, McCusker J, Bellavance F.
    Can Fam Physician; 2002 May 10; 48():905-12. PubMed ID: 12053635
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of St John's wort in major depression: a randomized controlled trial.
    Shelton RC, Keller MB, Gelenberg A, Dunner DL, Hirschfeld R, Thase ME, Russell J, Lydiard RB, Crits-Cristoph P, Gallop R, Todd L, Hellerstein D, Goodnick P, Keitner G, Stahl SM, Halbreich U.
    JAMA; 2001 Apr 18; 285(15):1978-86. PubMed ID: 11308434
    [Abstract] [Full Text] [Related]

  • 5. St. John's wort and Kava in treating major depressive disorder with comorbid anxiety: a randomised double-blind placebo-controlled pilot trial.
    Sarris J, Kavanagh DJ, Deed G, Bone KM.
    Hum Psychopharmacol; 2009 Jan 18; 24(1):41-8. PubMed ID: 19090505
    [Abstract] [Full Text] [Related]

  • 6. Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.
    Kasper S, Volz HP, Möller HJ, Dienel A, Kieser M.
    Eur Neuropsychopharmacol; 2008 Nov 18; 18(11):803-13. PubMed ID: 18694635
    [Abstract] [Full Text] [Related]

  • 7. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
    Brenner R, Azbel V, Madhusoodanan S, Pawlowska M.
    Clin Ther; 2000 Apr 18; 22(4):411-9. PubMed ID: 10823363
    [Abstract] [Full Text] [Related]

  • 8. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial.
    Mannel M, Kuhn U, Schmidt U, Ploch M, Murck H.
    J Psychiatr Res; 2010 Sep 18; 44(12):760-7. PubMed ID: 20181361
    [Abstract] [Full Text] [Related]

  • 9. The impact of missing data on clinical trials: a re-analysis of a placebo controlled trial of Hypericum perforatum (St Johns wort) and sertraline in major depressive disorder.
    Grobler AC, Matthews G, Molenberghs G.
    Psychopharmacology (Berl); 2014 May 18; 231(9):1987-99. PubMed ID: 24232445
    [Abstract] [Full Text] [Related]

  • 10. Treatment of somatoform disorders with St. John's wort: a randomized, double-blind and placebo-controlled trial.
    Müller T, Mannel M, Murck H, Rahlfs VW.
    Psychosom Med; 2004 May 18; 66(4):538-47. PubMed ID: 15272100
    [Abstract] [Full Text] [Related]

  • 11. Long-term effects of St. John's wort (Hypericum perforatum) treatment: a 1-year safety study in mild to moderate depression.
    Brattström A.
    Phytomedicine; 2009 Apr 18; 16(4):277-83. PubMed ID: 19299116
    [Abstract] [Full Text] [Related]

  • 12. The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medication.
    Gelenberg AJ, Shelton RC, Crits-Christoph P, Keller MB, Dunner DL, Hirschfeld RM, Thase ME, Russell JM, Lydiard RB, Gallop RJ, Todd L, Hellerstein DJ, Goodnick PJ, Keitner GI, Stahl SM, Halbreich U, Hopkins HS.
    J Clin Psychiatry; 2004 Aug 18; 65(8):1114-9. PubMed ID: 15323598
    [Abstract] [Full Text] [Related]

  • 13. A Double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder.
    Fava M, Alpert J, Nierenberg AA, Mischoulon D, Otto MW, Zajecka J, Murck H, Rosenbaum JF.
    J Clin Psychopharmacol; 2005 Oct 18; 25(5):441-7. PubMed ID: 16160619
    [Abstract] [Full Text] [Related]

  • 14. The efficacy of St. John's Wort in patients with minor depressive symptoms or dysthymia--a double-blind placebo-controlled study.
    Randløv C, Mehlsen J, Thomsen CF, Hedman C, von Fircks H, Winther K.
    Phytomedicine; 2006 Mar 18; 13(4):215-21. PubMed ID: 16423519
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and tolerability of hypericum extract WS 5572 versus placebo in mildly to moderately depressed patients. A randomized double-blind multicenter clinical trial.
    Kalb R, Trautmann-Sponsel RD, Kieser M.
    Pharmacopsychiatry; 2001 May 18; 34(3):96-103. PubMed ID: 11434406
    [Abstract] [Full Text] [Related]

  • 16. A randomized, double-blind, placebo-controlled trial of St John's wort for treating irritable bowel syndrome.
    Saito YA, Rey E, Almazar-Elder AE, Harmsen WS, Zinsmeister AR, Locke GR, Talley NJ.
    Am J Gastroenterol; 2010 Jan 18; 105(1):170-7. PubMed ID: 19809408
    [Abstract] [Full Text] [Related]

  • 17. Effects of Hypericum perforatum (St. John's wort) on hot flashes and quality of life in perimenopausal women: a randomized pilot trial.
    Al-Akoum M, Maunsell E, Verreault R, Provencher L, Otis H, Dodin S.
    Menopause; 2009 Jan 18; 16(2):307-14. PubMed ID: 19194342
    [Abstract] [Full Text] [Related]

  • 18. St John's wort extract (LI 160) in somatoform disorders: results of a placebo-controlled trial.
    Volz HP, Murck H, Kasper S, Möller HJ.
    Psychopharmacology (Berl); 2002 Nov 18; 164(3):294-300. PubMed ID: 12424553
    [Abstract] [Full Text] [Related]

  • 19. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA, Padmanabhan SK, Groark J, Brisard C, Farrington D.
    Clin Ther; 2009 Jun 18; 31 Pt 1():1405-23. PubMed ID: 19698901
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of St. John's wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial.
    Lecrubier Y, Clerc G, Didi R, Kieser M.
    Am J Psychiatry; 2002 Aug 18; 159(8):1361-6. PubMed ID: 12153829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.